Rukang Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rukang Zhang has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Chufan Cai
Ben May Department for Cancer Research, University of Chicago
32 shared publications - Freya Q. Zhang
Department of Medicine, The University of Chicago, Chicago, IL, USA
32 shared publications - Hao Fan
Department of Medicine, The University of Chicago, Chicago, IL 60637, USA
32 shared publications - Jiacheng Li
Department of Medicine, The University of Chicago, Chicago, IL, USA
32 shared publications - Jiayi Tu
Department of Medicine, The University of Chicago, Chicago, IL, USA
32 shared publications - Jing Chen
Department of Medicine, The University of Chicago, Chicago, IL, USA
32 shared publications
Latest Publications
- 18 June 2026
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 392 (6804) , eaea4041
Maternal trans-vaccenic acid shapes neonatal T cell development and early-life immune imprinting
How maternal nutrition influences neonatal immune development and imprinting through breastfeeding remains largely unclear. We report that maternal supplementation with trans-vaccenic acid (TVA), the predominant naturally occurring trans-fatty acid in human breast milk, promoted neonatal T cell development in mice. Neonates fed by mothers on a TVA-enriched diet showed an expanded naïve cluster of differentiation 4 (CD4 + ) T cell population and enhanced adaptive immunity against infection. TVA reprogrammed neonatal naïve CD4 + T cells through a G protein–coupled receptor–CCCTC-binding factor axis and promoted T helper cells (Th1)–skewing by cooperating with the transcription factor TBX21. Early-life exposure to maternal TVA via breastfeeding supported long-lasting antiviral immunity in adulthood. Our findings establish the multifaceted benefits of maternal nutrition and breastfeeding via TVA in promoting infant immune homeostasis and protective immunity.
- 18 June 2026
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 392 (6804) , eaea4041
Maternal trans-vaccenic acid shapes neonatal T cell development and early-life immune imprinting
How maternal nutrition influences neonatal immune development and imprinting through breastfeeding remains largely unclear. We report that maternal supplementation with trans-vaccenic acid (TVA), the predominant naturally occurring trans-fatty acid in human breast milk, promoted neonatal T cell development in mice. Neonates fed by mothers on a TVA-enriched diet showed an expanded naïve cluster of differentiation 4 (CD4 + ) T cell population and enhanced adaptive immunity against infection. TVA reprogrammed neonatal naïve CD4 + T cells through a G protein–coupled receptor–CCCTC-binding factor axis and promoted T helper cells (Th1)–skewing by cooperating with the transcription factor TBX21. Early-life exposure to maternal TVA via breastfeeding supported long-lasting antiviral immunity in adulthood. Our findings establish the multifaceted benefits of maternal nutrition and breastfeeding via TVA in promoting infant immune homeostasis and protective immunity.
- Open Access
- 2 April 2024
- Published by American Association for Cancer Research (AACR)
Figure S8 from NRAS Mutant Dictates AHCYL1-Governed ER Calcium Homeostasis for Melanoma Tumor Growth
Supplementary Figure 8. AHCYL1 deficiency causes cell growth attenuation, ER calcium decrease, and apoptosis in NRAS-Q61K overexpressed Mel-ST cells.
- 2 April 2024
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S8 from NRAS Mutant Dictates AHCYL1-Governed ER Calcium Homeostasis for Melanoma Tumor Growth
Supplementary Figure 8. AHCYL1 deficiency causes cell growth attenuation, ER calcium decrease, and apoptosis in NRAS-Q61K overexpressed Mel-ST cells.
- Open Access
- 2 April 2024
- Published by American Association for Cancer Research (AACR)
Table S1 from NRAS Mutant Dictates AHCYL1-Governed ER Calcium Homeostasis for Melanoma Tumor Growth
Supplemental Table 1. Transcription factor scan. Transcription factors candidates for AHCYL1 transcription were generated based on reported binding response elements that can match AHCYL1 promoter region sequence.
- 2 April 2024
- Published by American Association for Cancer Research (AACR)
Open AccessTable S1 from NRAS Mutant Dictates AHCYL1-Governed ER Calcium Homeostasis for Melanoma Tumor Growth
Supplemental Table 1. Transcription factor scan. Transcription factors candidates for AHCYL1 transcription were generated based on reported binding response elements that can match AHCYL1 promoter region sequence.
- Open Access
- 2 April 2024
- Published by American Association for Cancer Research (AACR)
Figure S5 from NRAS Mutant Dictates AHCYL1-Governed ER Calcium Homeostasis for Melanoma Tumor Growth
Supplementary Figure 5. IP3R deficiency doesn’t change AHCYL1 protein level in the whole cell lysates.
- 2 April 2024
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from NRAS Mutant Dictates AHCYL1-Governed ER Calcium Homeostasis for Melanoma Tumor Growth
Supplementary Figure 5. IP3R deficiency doesn’t change AHCYL1 protein level in the whole cell lysates.
- Open Access
- 2 April 2024
- Published by American Association for Cancer Research (AACR)
Figure S3 from NRAS Mutant Dictates AHCYL1-Governed ER Calcium Homeostasis for Melanoma Tumor Growth
Supplementary Figure 3. AHCYL2 does not overexpress and is not critical in human NRAS-mutated melanoma as AHCYL1.
- 2 April 2024
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from NRAS Mutant Dictates AHCYL1-Governed ER Calcium Homeostasis for Melanoma Tumor Growth
Supplementary Figure 3. AHCYL2 does not overexpress and is not critical in human NRAS-mutated melanoma as AHCYL1.
- Open Access
- 2 April 2024
- Published by American Association for Cancer Research (AACR)
Figure S10 from NRAS Mutant Dictates AHCYL1-Governed ER Calcium Homeostasis for Melanoma Tumor Growth
Supplementary Figure 10. CREB doesn’t positively regulate AHCYL1 transcription.
- 2 April 2024
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S10 from NRAS Mutant Dictates AHCYL1-Governed ER Calcium Homeostasis for Melanoma Tumor Growth
Supplementary Figure 10. CREB doesn’t positively regulate AHCYL1 transcription.
- Open Access
- 2 April 2024
- Published by American Association for Cancer Research (AACR)
Table S1 from NRAS Mutant Dictates AHCYL1-Governed ER Calcium Homeostasis for Melanoma Tumor Growth
Supplemental Table 1. Transcription factor scan. Transcription factors candidates for AHCYL1 transcription were generated based on reported binding response elements that can match AHCYL1 promoter region sequence.
- 2 April 2024
- Published by American Association for Cancer Research (AACR)
Open AccessTable S1 from NRAS Mutant Dictates AHCYL1-Governed ER Calcium Homeostasis for Melanoma Tumor Growth
Supplemental Table 1. Transcription factor scan. Transcription factors candidates for AHCYL1 transcription were generated based on reported binding response elements that can match AHCYL1 promoter region sequence.
- Open Access
- 2 April 2024
- Published by American Association for Cancer Research (AACR)
Figure S11 from NRAS Mutant Dictates AHCYL1-Governed ER Calcium Homeostasis for Melanoma Tumor Growth
Supplementary Figure 11. There is positive correlation between ATF2 and AHCYL1 mRNA levels in human cutaneous melanoma patients by TCGA analysis.
- 2 April 2024
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S11 from NRAS Mutant Dictates AHCYL1-Governed ER Calcium Homeostasis for Melanoma Tumor Growth
Supplementary Figure 11. There is positive correlation between ATF2 and AHCYL1 mRNA levels in human cutaneous melanoma patients by TCGA analysis.
- Open Access
- 2 April 2024
- Published by American Association for Cancer Research (AACR)
Figure S1 from NRAS Mutant Dictates AHCYL1-Governed ER Calcium Homeostasis for Melanoma Tumor Growth
Supplementary Figure 1. AHCYL1 is selectively critical for NRAS-mutated but not for BRAF-mutated human melanoma cells.
- 2 April 2024
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from NRAS Mutant Dictates AHCYL1-Governed ER Calcium Homeostasis for Melanoma Tumor Growth
Supplementary Figure 1. AHCYL1 is selectively critical for NRAS-mutated but not for BRAF-mutated human melanoma cells.